India Pharma Outlook Team | Saturday, 23 August 2025
In the next years, DavaIndia, a private generic pharmacy retail chain owned by Gujarat-based Zota Healthcare, plans to grow from its existing 1,600 locations to over 3,000.
The company claims that it uses healthcare technology to accelerate its growth, with its AI assisted supply chain, predictive inventory, and automated warehousing helping to mitigate human error or something like that and better allocate deficits.
It has served about 1.5 crore customers via more than 1,600 stores across 28 states and 6 union territories. The generics store has a foothold from the metros to smaller towns from cities like Pune, Delhi, Kolkata, Kochi, and Surat to the hinterlands of the country.
"In the next few years, we expect to have more than 3,000 stores, zonal automated warehouses. With diagnostics, wellness, and nutraceuticals as other complementary streams, the go-give to the market are bundles like diabetes care kit and immunity packs.
The future goes integrated, preventive, and tech-based healthcare, and we're very enthusiastic about pioneering that," said Dr Sujit Paul, group CEO of Zota Healthcare Ltd. With yet just 2-3% awareness, the company is expecting exponential potential for its business.
Also Read: Suneeta Reddy Sells Rs 1,489 Crore Stake in Apollo Hospitals to Cut Debt
"Currently growing at about 15-20% every year, we are now looking at a further 20-25% growth per annum for ourselves. We expect that there is ample room for 5X growth of our reach, especially when the health narrative is setting toward affordability and reachability to all," he added.
To ensure scalability and control, the company has developed a hybrid model that combines company-operated (CoCo) and FOFO outlets. Through its multilingual e-commerce site, 60-minute delivery model, app, and hotline, it also has an online presence.
